Mayinglong Pharmaceutical Group Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Youzhang Xia
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
Estimating The Intrinsic Value Of Mayinglong Pharmaceutical Group Co., Ltd. (SHSE:600993)
Oct 01
What Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) P/E Is Not Telling You
Aug 19Mayinglong Pharmaceutical Group's (SHSE:600993) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 24Mayinglong Pharmaceutical Group (SHSE:600993) Has A Rock Solid Balance Sheet
Jun 19Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Right But Growth Is Lacking After Shares Rocket 26%
May 07Investors Don't See Light At End Of Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Tunnel
Mar 22CEO
Youzhang Xia (45 yo)
no data
Tenure
CN¥1,800,000
Compensation
Mr. Youzhang Xia serves as General Manager and Director at Mayinglong Pharmaceutical Group Co., Ltd. and served as its Deputy General Manager and Secretary of the Board.